CareDx Inc - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
CDNA Nasdaq 8071 https://www.caredx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CareDx Inc

Cathie Wood pours millions into these 2 stocks — this is what makes them attractive buys - Feb 1st, 2023 2:48 pm
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Jan 27th, 2023 1:30 pm
CareDx (NASDAQ:CDNA) delivers shareholders splendid 20% CAGR over 5 years, surging 9.8% in the last week alone - Jan 26th, 2023 1:21 pm
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice - Jan 26th, 2023 12:01 pm
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium - Jan 11th, 2023 12:01 pm
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022 - Jan 9th, 2023 12:00 pm
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients - Dec 21st, 2022 11:00 pm
Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors - Dec 14th, 2022 12:00 pm
CareDx Announces $50 Million Stock Repurchase Program - Dec 6th, 2022 1:01 pm
13 Best Genomics Stocks To Buy Now - Dec 5th, 2022 8:49 pm
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance - Dec 1st, 2022 1:15 pm
Here's Why CareDx (CDNA) Could be Great Choice for a Bottom Fisher - Nov 17th, 2022 2:55 pm
CareDx (CDNA) Loses 22.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nov 11th, 2022 2:35 pm
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community - Nov 11th, 2022 12:01 pm
Analysts Have Been Trimming Their CareDx, Inc (NASDAQ:CDNA) Price Target After Its Latest Report - Nov 6th, 2022 12:34 pm
CareDx To Participate in Upcoming Investor Conferences - Nov 4th, 2022 11:00 am
CareDx (CDNA) Reports Q3 Loss, Lags Revenue Estimates - Nov 3rd, 2022 10:15 pm
CareDx Reports Third Quarter 2022 Results - Nov 3rd, 2022 8:01 pm
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week - Nov 2nd, 2022 11:01 am
Do You Think CareDx (CDNA) Has Huge Growth Potential? - Nov 1st, 2022 4:19 pm